Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Japan In Talks With Baxter, GSK For Emergency Flu Vaccines

This article was originally published in PharmAsia News

Executive Summary

Japan's Health Ministry is conducting separate talks with a pair of international drug makers to provide vaccines to prevent a pandemic of new virulent flu strains. Baxter International of the United States and GlaxoSmithKline of the United Kingdom have held talks with the ministry about getting marketing approval in Japan that would allow them to begin shipping supplies within three to six months after they apply. Both companies already have received orders for pre-pandemic flu vaccines from the U.S. and U.K. governments. (Click here for more - a subscription may be required



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts